Statin treatment and cerebral microbleeds: A systematic review and meta-analysis

[1]  V. Mok,et al.  The role of cerebral microbleeds in the incidence of post-stroke dementia , 2020, Journal of the Neurological Sciences.

[2]  E. Boersma,et al.  A revised systematic review and meta‐analysis on the effect of statins on D‐dimer levels , 2019, European journal of clinical investigation.

[3]  A. Alexandrov,et al.  Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed , 2019, Annals of clinical and translational neurology.

[4]  S. Salloway,et al.  Are lobar microbleeds of diagnostic value in the community? , 2019, Neurology.

[5]  S. Larsson,et al.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis , 2019, JAMA neurology.

[6]  Q. Chai,et al.  Effect of Low-Dose Statins and Apolipoprotein E Genotype on Cerebral Small Vessel Disease in Older Hypertensive Patients: A Subgroup Analysis of a Randomized Clinical Trial. , 2018, Journal of the American Medical Directors Association.

[7]  R. Delgado-Mederos,et al.  Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke , 2018, Scientific Reports.

[8]  S. Yamaguchi,et al.  Serum Lipid Fractions and Cerebral Microbleeds in a Healthy Japanese Population , 2017, Cerebrovascular Diseases.

[9]  D. Werring,et al.  Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA , 2016, Neurology.

[10]  Michelle R. Caunca,et al.  Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study , 2016, Journal of the American Heart Association.

[11]  S. Misra,et al.  High‐dose statin therapy and risk of intracerebral hemorrhage: a meta‐analysis , 2016, Acta neurologica Scandinavica.

[12]  A. Alexandrov,et al.  Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden: A Meta-analysis. , 2016, JAMA neurology.

[13]  R. D'Agostino,et al.  Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study , 2016, Journal of the American Heart Association.

[14]  L. Schad,et al.  Statin Therapy and the Development of Cerebral Amyloid Angiopathy—A Rodent in Vivo Approach , 2016, International journal of molecular sciences.

[15]  Ning Wang,et al.  Quantity of Cerebral Microbleeds, Antiplatelet Therapy, and Intracerebral Hemorrhage Outcomes: A Systematic Review and Meta-analysis. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[16]  S. Greenberg,et al.  Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy , 2014, Neurology.

[17]  Kwang-Soo Lee,et al.  Cerebral Microbleeds and Functional Outcomes after Ischemic Stroke , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  P. Wolf,et al.  Risk Factors, Stroke Prevention Treatments, and Prevalence of Cerebral Microbleeds in the Framingham Heart Study , 2014, Stroke.

[19]  V. Mok,et al.  Prestroke Statins, Progression of White Matter Hyperintensities, and Cognitive Decline in Stroke Patients with Confluent White Matter Hyperintensities , 2014, Neurotherapeutics.

[20]  J. Broderick,et al.  Apolipoprotein E, Statins, and Risk of Intracerebral Hemorrhage , 2013, Stroke.

[21]  D. Haussen,et al.  Statin Use and Microbleeds in Patients With Spontaneous Intracerebral Hemorrhage , 2012, Stroke.

[22]  R. Marshall,et al.  Statins and Cerebral Hemodynamics , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  W. Smoker,et al.  Previous Statin Use Is Not Associated With an Increased Prevalence or Degree of Gradient-Echo Lesions in Patients With Acute Ischemic Stroke or Transient Ischemic Attack , 2011, Stroke.

[24]  Eric E. Smith,et al.  MRI Markers of Small Vessel Disease in Lobar and Deep Hemispheric Intracerebral Hemorrhage , 2010, Stroke.

[25]  M. Vermeulen,et al.  HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY , 2009, Neurology.

[26]  M. van Buchem,et al.  Risk Factors for Cerebral Microbleeds in the Elderly , 2008, Cerebrovascular Diseases.

[27]  M. Hennerici,et al.  Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study , 2008, Neurology.

[28]  A. Hofman,et al.  Prevalence and risk factors of cerebral microbleeds , 2008, Neurology.

[29]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[30]  J. Roh,et al.  Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions , 2002, Stroke.

[31]  Byeong-Chae Kim,et al.  Impact of Microbleeds on Outcome Following Recanalization in Patients With Acute Ischemic Stroke , 2019, Stroke.